September 16, 2009 AorTech AGM Statement

September 16, 2009

At the Annual General Meeting of AorTech International plc to be held 16 September 2009, Chairman Jon Pither will make the following statement:

“Polymer and manufactured component volume and revenue continue to grow as a consequence of the maturation of existing licenses and the addition of new ones. Now entering its fourth year of long term implant use, the performance of Elast-Eon™ polymers continues to be defect-free. These implants now number in the millions and are comprised of a growing spectrum of applications. 

“We are particularly excited about the progress of our component business. From our 25,000 square foot ISO certified manufacturing facility we are now routinely shipping various components for spinal disc and circulatory support devices. Our entry into the $100m header market will be punctuated by first human use in 2010 and we are in the late stages of qualifying our polymer heart valve technology for use in circulatory support devices. 

 “There have been no significant changes in the financial position of the Company since 31 March 2009."